Vimarsana
Biggest News Aggregation in the World

Page 3 - Andera Croissance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andera Croissance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andera Croissance Today - Breaking & Trending Today

SoniVie Raises $60m in Round C Financing, and Appoints New Board Members - Vimarsana News

SoniVie Raises $60m in Round C Financing, and Appoints New Board Members

/PRNewswire/ -- SoniVie Ltd. ("SoniVie" or the "Company"), a medical device company developing a proprietary solution to treat hypertension, announced today...

DGAP-News: Andera Partners strengthens its Life Sciences team with a new partner - Vimarsana News

DGAP-News: Andera Partners strengthens its Life Sciences team with a new partner

DGAP-News: Andera Partners / Key word(s): Personnel Andera Partners strengthens its Life Sciences team with a new partner 07.07.2022 / 10:15 The issuer is solely responsible for

ImCheck Closes Upsized EUR 96 Million (USD 103 Million) - Vimarsana News

ImCheck Closes Upsized EUR 96 Million (USD 103 Million)

Significant round will enable the Company to advance ICT01, its lead anti-butyrophilin 3A antibody, to completion of randomized Phase II trialsSeries C...

Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension - Vimarsana News

Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension

/PRNewswire/ -- Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing a best-in-class, novel therapy for...

DGAP-News: Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension - Vimarsana News

DGAP-News: Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension

DGAP-News: Andera Partners / Key word(s): Financing Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension 08.06.2022 / 14:05 The issuer is solely responsible for the content of th...